Icon

DYAZIDE (nda016042)- (25MG;50MG,25MG;37.5MG)

HYDROCHLOROTHIAZIDE; TRIAMTERENE GLAXOSMITHKLINE LLC
25MG;50MG,25MG;37.5MG
No No
Expired Expired
None None
None No
DYAZIDE is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. DYAZIDE is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked. DYAZIDE may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers.
4 0 3
Total Other Developers None
Drugs with Suitability No
25MG;50MG ** ** - - -
25MG;37.5MG ** ** - 3 -
NDA Sales Available Total Generic Sales Available
No 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ** *** ******* *******, ***. *********** **** * *** *, *******, ******* (**) *****, ****** ****** (***) ***
****** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.